Trial Profile
Roflumilast in patients with chronic obstructive pulmonary disease and ischaemic heart disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 01 Dec 2015 New trial record